Skip to main content

Table 1 Patient characteristics and incidence (episode/1000 admission)

From: Surveillance study of species distribution, antifungal susceptibility and mortality of nosocomial candidemia in a tertiary care hospital in China

 

Candidaspecies

 

Total

C. tropicalis

C. albicans

C. parapsilosis

C. glabrata

C. krusei

C. guilliermondii

Other*

 

(n = 133)

(n = 38)

(n = 31)

(n = 26)

(n = 11)

(n = 3)

(n = 6)

(n = 18)

 

100.0%

28.6%

23.3%

19.5%

8.3%

2.3%

4.5%

13.5%

Patients characteristic

        

Age (years)

        

1-14

3(2.3)

1(33.3)

1(33.3)

0(0)

0(0)

0(0)

0(0)

1(33.3)

15-49

29(21.8)

7(24.1)

9(31.0)

5(17.2)

3(10.3)

0(0)

1(3.4)

4(13.8)

50-65

40(30.1)

13(32.5)

7(17.5)

8(20.0)

3(7.5)

1(2.5)

4(10.0)

4(10.0)

>65

61(45.9)

17(27.9)

14(23.0)

13(21.3)

5(8.2)

2(3.3)

1(1.6)

9(14.8)

Gender

        

Male

91(68.4)

28(30.8)

20(22.0)

18(19.8)

6(6.6)

2(2.2)

2(2.2)

15(16.5)

Female

42(31.6)

10(23.8)

11(26.2)

8(19.0)

5(11.9)

1(2.4)

4(9.5)

3(7.1)

Underline diseases n (%)

        

Intestinal fistula/abdominal infection

74(55.7)

14(18.9)

20(27.0)

15(20.3)

6(8.1)

3(4.1)

5(6.8)

11(14.9)

Solid tumor

8(6.0)

2(25.0)

2(25.0)

1(12.5)

2(25.0)

0(0)

0(0)

1(12.5)

Respiratory dysfunctiona

17(12.8)

11(64.7)

3(17.6)

1(5.9)

0(0)

0(0)

0(0)

2(11.8)

Gastrointestinal pathologyb

14(10.5)

4(28.6)

1(7.1)

5(35.7)

1(7.1)

0(0)

1(7.1)

2(14.3)

Haematological malignancy

6(4.5)

5(83.3)

1(16.7)

0(0)

0(0)

0(0)

0(0)

0(0)

Acute renal failurec

11(8.3)

1(9.1)

3(27.3)

4(36.4)

2(18.2)

0(0)

0(0)

1(9.1)

Burns

3(2.3)

1(33.3)

1(33.3)

0(0)

0(0)

0(0)

0(0)

1(33.3)

Receipt of corticosteroids

76(57.1)

21(27.6)

17(22.4)

15(19.7)

5(6.6)

1(1.3)

2(2.6)

15(19.7)

Chemotherapy

6(4.5)

5(83.3)

1(16.7)

0(0)

0(0)

0(0)

0(0)

0(0)

Presence of CVCd

61(45.9)

19(31.1)

13(21.3)

11(18.0)

5(8.2)

2(3.3)

4(6.6)

7(11.5)

Parenteral nutrition

61(45.9)

20(32.8)

18(29.5)

6(9.8)

8(13.1)

1(1.6)

3(4.9)

5(8.2)

Mechanical ventilation

17(12.8)

6(35.3)

5(29.4)

2(11.8)

2(11.8)

0(0)

0(0)

2(11.8)

In the ICU at diagnosis

39(29.3)

14(35.9)

9(23.1)

8(20.5)

3(7.7)

2(5.1)

0(0)

3(7.7)

Neutropeniae

6(4.5)

2(33.3)

2(33.3)

0(0)

2(33.3)

0(0)

0(0)

0(0)

Dialysis

2(1.5)

0(0)

1(50.0)

1(50.0)

0(0)

0(0)

0(0)

0(0)

Exposition to antibiotics

80(60.2)

29(36.3)

23(28.8)

20(25.0)

3(3.8)

2(2.6)

1(1.3)

2(2.6)

Treatment with fluconazole

61(45.9)

23(37.7)

18(29.5)

5(8.2)

3(4.9)

3(4.9)

2(3.3)

7(11.5)

Incidence (episodes/1000 admissions)

        

2009

0.71

0.19

0.22

0.11

0.06

0.02

0.04

0.06

2010

0.77

0.18

0.15

0.23

0.02

0.03

0.03

0.15

2011

0.85

0.31

0.19

0.13

0.13

0

0.03

0.12

  1. *Others include: C. pelliculosa(8), C. famata(7) and C. haemulonii(2).
  2. aIncludes the following diseases: pneumonia, chronic obstructive pulmonary disease, and acute respiratory distress syndrome.
  3. bIncludes the following diseases: cholecystitis, pancreatitis, peritonitis, and hepatitis.
  4. cAcute renal failure was defined as sudden and often temporary loss of kidney function with nitrogen waste retention and hypourocrinia.
  5. d CVC central venous catheter.
  6. eNeutropenia was defined as absolute neutrophil count <500 cells/μl.